Aspen Aerogels, Inc. (ASPN) Stock Forecast
ASPN analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.17 / 5 from 6 analysts
- Price target
- $7.75 average of analyst targets
- Upside to target
- +49.3% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $-0.09
- 52-week range
- $2.57 – $8.50
ASPN analyst ratings
6 analystsNumber of analysts at each rating.
ASPN price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ASPN earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.07 | −$0.09 | −$0.03 | −$0.06 | −10.0% | 3 |
| Current fiscal year (2026) | −$0.58 | −$0.72 | −$0.42 | −$0.49 | −17.5% | 4 |
| Next fiscal year (2027) | −$0.15 | −$0.29 | −$0.08 | −$0.58 | +73.1% | 3 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ASPN revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $72.1M | $69.6M | $76.0M | −1.3% | 5 |
| Current fiscal year (2026) | $224.7M | $219.6M | $240.0M | −17.1% | 5 |
| Next fiscal year (2027) | $280.4M | $262.5M | $325.0M | +24.8% | 5 |
ASPN EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ASPN revenue: reported and forecast
ASPN EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.13 | −$0.07 | −$0.07 | −$0.07 | −$0.07 | −48.4% | 2 up · 1 down |
| Current fiscal year (2026) | −$0.72 | −$0.63 | −$0.63 | −$0.63 | −$0.58 | −19.7% | 3 up · 0 down |
| Next fiscal year (2027) | −$0.10 | −$0.15 | −$0.15 | −$0.15 | −$0.15 | +48.6% | 1 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ASPN earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ASPN beat in 9 of 12.
What analysts expect from ASPN
6 analysts cover Aspen Aerogels; their consensus rating is buy (4.17 on a 1–5 scale, where 5 is a strong buy). The average price target is $7.75, 49.3% above the latest close of $5.19. Analysts expect earnings of −$0.58 per share for 2026, −17.5% from a year earlier. For 2027 the average estimate is −$0.15 per share on revenue of $280.4 million. Aspen Aerogels beat the EPS estimate in 9 of the last 12 quarters.
Related: ASPN income statement, ASPN key metrics, ASPN chart. See the ASPN stock overview for the latest quote and news.
ASPN forecast FAQ
What is Aspen Aerogels's price target?
The average analyst price target for Aspen Aerogels is $7.75, 49.3% above the latest close of $5.19.
Is Aspen Aerogels a buy, hold or sell?
Of 6 analysts covering Aspen Aerogels, 4 rate it a strong buy, 0 a buy, 1 a hold, 1 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Aspen Aerogels's EPS forecast?
Analysts forecast −$0.58 per share for 2026 (range −$0.72 to −$0.42); for 2027 the estimate is −$0.15.
What is Aspen Aerogels's revenue forecast?
The average revenue estimate for 2026 is $224.7 million, growth of −17.1%; for 2027 it is $280.4 million.
When does Aspen Aerogels report earnings?
Aspen Aerogels is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens; the EPS estimate is $-0.09.
Does Aspen Aerogels usually beat earnings estimates?
Aspen Aerogels reported EPS at or above the analyst estimate in 9 of the last 12 quarters.